• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[孕激素受体水平在子宫内膜癌中的预后意义]

[The prognostic significance of progesterone receptor level in endometrial cancer].

作者信息

Nyholm H C, Christensen I J, Nielsen A L

机构信息

Gynaekologisk-obstetrisk afdeling, H:S Hvidovre Hospital.

出版信息

Ugeskr Laeger. 1997 Jan 27;159(5):601-4.

PMID:9045451
Abstract

Oestrogen receptor (ER) and progesterone receptor (PR) contents were determined by biochemical (dextran charcoal-coated (DCC) assay) and immunohistochemical (ICA) methods in biopsies from 145 primary endometrial adenocarcinomas. Correlations between receptor contents and cancer specific survival were examined in a multivariate analysis including histopathological characteristics. Median patient follow-up time was 67 months with 18 cancer deaths. "High" PR levels correlated significantly (p = 0.004) with survival, independently of stage risk group (stages Ia-Ib vs Ic-IV). Patient age and histological grade were prognostic factors in a univariate setting but these parameters were eliminated in the multivariate model. The association between PR contents and cancer survival suggests that determination of PR can be of importance in the evaluation of endometrial cancer.

摘要

采用生化方法(葡聚糖包被活性炭(DCC)分析法)和免疫组织化学方法(ICA)测定了145例原发性子宫内膜腺癌活检组织中的雌激素受体(ER)和孕激素受体(PR)含量。在一项包括组织病理学特征的多变量分析中,研究了受体含量与癌症特异性生存率之间的相关性。患者的中位随访时间为67个月,有18例癌症死亡。“高”PR水平与生存率显著相关(p = 0.004),与分期风险组无关(Ia-Ib期与Ic-IV期)。在单变量分析中,患者年龄和组织学分级是预后因素,但在多变量模型中这些参数被排除。PR含量与癌症生存率之间的关联表明,PR的测定在子宫内膜癌评估中可能具有重要意义。

相似文献

1
[The prognostic significance of progesterone receptor level in endometrial cancer].[孕激素受体水平在子宫内膜癌中的预后意义]
Ugeskr Laeger. 1997 Jan 27;159(5):601-4.
2
Progesterone receptor levels independently predict survival in endometrial adenocarcinoma.孕激素受体水平可独立预测子宫内膜腺癌的生存率。
Gynecol Oncol. 1995 Dec;59(3):347-51. doi: 10.1006/gyno.1995.9964.
3
Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.一大群子宫内膜样子宫内膜癌患者中雌激素受体α和β以及孕激素受体A和B的表达
Gynecol Oncol. 2009 Mar;112(3):537-42. doi: 10.1016/j.ygyno.2008.10.032. Epub 2008 Dec 23.
4
A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.类固醇受体、细胞增殖因子Ki-67和蛋白p53免疫组化检测在子宫内膜癌中的意义
Gynecol Oncol. 2004 Apr;93(1):34-40. doi: 10.1016/j.ygyno.2003.12.038.
5
Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.雌激素受体和孕激素受体肿瘤表达在丹麦卵巢癌患者中的预后价值:来自“MALOVA”卵巢癌研究
Oncol Rep. 2007 Nov;18(5):1051-9.
6
Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.孕激素受体免疫组织化学在子宫内膜癌中的预后意义
Gynecol Oncol. 1998 Jun;69(3):220-5. doi: 10.1006/gyno.1998.5023.
7
Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.孕激素受体免疫组化对子宫内膜癌淋巴结转移的预后意义
Gynecol Oncol. 1999 Mar;72(3):351-9. doi: 10.1006/gyno.1998.5286.
8
[Estrogen and progesterone receptors in endometrial carcinoma].[子宫内膜癌中的雌激素和孕激素受体]
Zhonghua Fu Chan Ke Za Zhi. 1997 Jul;32(7):418-21.
9
Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.雌激素受体、孕激素受体、Ki67、c-erbB-2及p53在子宫内膜癌中的预后意义
J Med Assoc Thai. 2008 Dec;91(12):1779-84.
10
Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer.尿激酶型纤溶酶原激活剂及其受体和1型抑制剂在子宫内膜癌中的临床相关性
Gynecol Oncol. 2001 Jan;80(1):48-55. doi: 10.1006/gyno.2000.6015.